Neonatal Glycogen Storage Disease Type IA: A Rare Presentation

Area of Science:

• Biochemistry
• Pediatrics
• Genetics

Background:

• Glucose homeostasis is vital for the central nervous system and energy production, relying on glycogen metabolism.
• Glycogen storage diseases (GSDs) result from enzymatic defects in glycogen breakdown, often affecting the liver and causing hepatomegaly, hypoglycemia, and neurological issues.
• GSD Type Ia is a severe inherited metabolic disorder with high morbidity and mortality if untreated, typically manifesting in early infancy.

Purpose of the Study:

• To present a case of a newborn diagnosed with Glycogen storage disease Type Ia.
• To highlight the importance of recognizing early clinical and metabolic red flags for GSD Ia in neonates.
• To emphasize the critical role of timely and appropriate management in improving patient outcomes.

Main Methods:

• Clinical case presentation of a male newborn with symptoms including hypoglycemia, metabolic acidosis, and hyperlactatemia.
• Diagnostic workup involving biochemical tests (glucose, liver enzymes, triglycerides) and abdominal ultrasound.
• Confirmation of diagnosis through genetic testing for GSD Type Ia.
• Management involved intravenous glucose, followed by a specialized formula and frequent dextrin supplementation.

Main Results:

• The patient presented with severe hypoglycemia unresponsive to initial measures, metabolic acidosis, hyperlactatemia, and elevated liver enzymes.
• Genetic testing confirmed the diagnosis of GSD Type Ia.
• The infant was successfully managed with a galactose-free formula, frequent feedings, and dextrin, showing normal physical development at 7 months without hepatomegaly.
• Continuous glucose monitoring and frequent feeding strategies were implemented.

Conclusions:

• Hypoglycemia and early weight loss in newborns, especially with accompanying metabolic derangements like hyperlactatemia and acidosis, are critical indicators for considering glycogen metabolism disorders.
• GSD Type Ia can present early, contrary to typical presentations, necessitating vigilant diagnostic approaches.
• Avoiding fasting and hypoglycemia is paramount for optimal cognitive development, overall prognosis, and preventing metabolic complications in GSD Ia patients.